Vice President, Clinical Development
Olga Uspenskaya, M.D., Ph.D., is a neurologist and serves at Prevail Therapeutics as Vice President, Clinical Development. She earned her M.D. and completed a residency in neurology at the First Moscow State Medical University. Subsequently, Olga completed a Ph.D. program in neurosciences at First Moscow State Medical University and Ludwig-Maximilians University, Munich, Germany; and a postdoctoral fellowship at the Sorbonne University Hospital Pitié-Salpêtrière, Paris, France. During her clinical and research career Olga held academic positions which included research grants and lecturing on neurology topics. Olga has published in peer-reviewed clinical related journals, contributed to the chapters in neurology textbooks, as well as presented at neurology conferences worldwide.
Prior to joining Prevail, Olga served as senior medical director at IQVIA where she was responsible for the medical strategy of the neurology portfolio and was overseeing execution of CNS clinical trials across different stages of clinical development.